john lechleiter will be joining us. carney testifies, political pressure intensifies. he answers questions in the house of lords today. will he finished out his term? earnings trickling in this morning. proctor and gamble is up next, earnings per share at $1.03, above estimates and reaffirming its 2017 forecast. earnings she goes, slightly higher, revenue and outlook as expected. david: let's focus on the syngenta deal. we are joined by jason miner in senior analyst with bloomberg, and tara patel. you., let's start with what is going on with syngenta and the e.u. competition authorities? jason: we are at a remarkable time. we have almost $200 billion worth of deals happening and syngenta-cam china is second down the line, dupont is first. third is bayer and monsanto. what will be the impact on competition? we are looking at a world where the farmers feared these companies are looking for a bigger share of their wallet and the companies say they are looking to boost innovation. david: they say it will least be into the next quarter -- the first quarter of next year. i think you are looking at a difference between a big, china, versus the mindset we face when we look at a publicly traded compa